Search
×
FR

Placeholder headline

This is just a placeholder headline

API STD 521: Guide for Pressure-relieving and Depressuring Systems – Edition 6

$

682

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 653: Tank Inspection, Repair, Alteration, and Reconstruction – Edition 4

$

507

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z662:19 – Oil and gas pipeline systems

$

1197

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series-18: Storage of hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z246.2-14 – Emergency preparedness and response for petroleum and natural gas industry systems

$

596

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series:22 – Storage of hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z731-09 (R2014) – Emergency Preparedness and Response

$

177

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z662:23 – Oil and gas pipeline systems

$

1197

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series:26 – Storage of Hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA B51:24 Boiler, Pressure Vessel, and Pressure Piping Code

$

389

BUY NOW

ISO 21474:2024

ISO 21474:2024 In vitro diagnostic medical devices – Multiplex molecular testing for nucleic acids – Part 3: Interpretation and reports

CDN $186.00

Description

This document gives the general requirements for interpretation and reporting of multiplex molecular tests which simultaneously identify two or more nucleic acid target sequences of interest. This document is applicable to all multiplex methods used for examination using in vitro diagnostic (IVD) medical devices and laboratory developed tests (LDTs). It provides information for both qualitative and quantitative detection of nucleic acid target sequences.

This document is intended as guidance for multiplex examinations that detect or quantify human nucleic acid target sequences and microbial pathogen nucleic acid target sequences from human clinical specimens.

This document is applicable to any molecular IVD examination performed by medical laboratories. It is also intended to be used by laboratory customers, IVD developers and manufacturers, biobanks, institutions, commercial organizations performing biomedical research, and regulatory authorities. This document is not applicable to metagenomic massive parallel sequencing (MPS), but it is applicable to multiplex molecular methods including 16S sequencing.

Edition

1

Published Date

2024-11-15

Status

PUBLISHED

Pages

14

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document gives the general requirements for interpretation and reporting of multiplex molecular tests which simultaneously identify two or more nucleic acid target sequences of interest. This document is applicable to all multiplex methods used for examination using in vitro diagnostic (IVD) medical devices and laboratory developed tests (LDTs). It provides information for both qualitative and quantitative detection of nucleic acid target sequences.

This document is intended as guidance for multiplex examinations that detect or quantify human nucleic acid target sequences and microbial pathogen nucleic acid target sequences from human clinical specimens.

This document is applicable to any molecular IVD examination performed by medical laboratories. It is also intended to be used by laboratory customers, IVD developers and manufacturers, biobanks, institutions, commercial organizations performing biomedical research, and regulatory authorities. This document is not applicable to metagenomic massive parallel sequencing (MPS), but it is applicable to multiplex molecular methods including 16S sequencing.

Previous Editions

Can’t find what you are looking for?

Please contact us at: